Petros Pharmaceuticals partners with Innolitics
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 20 2025
0mins
Should l Buy ?
Partnership Announcement: Petros Pharmaceuticals has partnered with Innolitics to enhance its SaaS platform, leveraging Innolitics' expertise in software development for medical devices and knowledge management systems used by Fortune 100 companies.
Platform Enhancements: The collaboration aims to integrate cloud-based components such as AI and cybersecurity into the platform, providing a scalable solution for prescription treatments and pharmaceutical sponsors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
